DAFTAR PUSTAKA

1) Abbas A, A.H. Lichmant, dan Pober JS. 1997. Antigen Presenttion and Cell
Antigen Recognition. In: Cellular and Molecular Immunology . 3rd ed. WB
Saunders Philadelphia.P. 116-35.

2) A.Harryanto Reksodlputro, 1994. Mekanisme Anemia Defisiensi Besi. Hematologi-

Onkologi Medik Bagian Ilmu Penyakit Dalam Fakultas Kedokteran Universitas
Indonesia Cermin Dunia Kedokteran, No. 95.

3) Benjamin. C, 2001. Blood Cell. http// www.americasblood.org/ America’s Blood

Centers. Tanggal akses 26 Oktober 2009.

4) Baratawidjaja, Karnen Garna, 1991. Imunologi Dasar, Edisi ke dua Jakarta:Balai

Penerbit FKUI

5) Baratawidjaja, KG, 2000. Imunologi Dasar, Edisi ke empat Penerbit Fakultas

Kedokteran Universitas Indonesia Jakarta

6) Baratawidjaja KG. Imunologi Dasar, 2006. Edisi ke tujuh. Penerbit Fakultas

Kedokteran Universitas Indonesia Jakarta.

7) C.G.G.J.Van Steenis, D.den Hoed, Bloembergen, P.J Eryma, 2003. Flora untuk
Sekolah di Indonesia. PT Pradnya Paramita, Jakrata.

8) Dalimartha.S. 2003. Atlas Tumbuhan Obat .Puspa Swara jilid 1-3. Jakarta.

9) Delves PJ, Roitt IM. 2001. The immune system. First of two parts. N. Eng J Med;
343(1):37-49

10) Djauhariya, E. dan Hernani. 2004. Gulma Berkhasiat Obat. Penebar Swadaya.
Jakarta.

11) Departemen Keshatan R.I: Kep. Menkes. No.47 Tahun 1993 tentang
Kebijaksanaan Obat Nasional, Jakarta, 1983 (101 hal)

12) Drueke TB, Locatelli F, Clyne N, Eckard, KU, Macdougall IC, Tsakikis D, Surger
HU, Scherhag A. ,2006. “Normalization of hemoglobin evel in patients with
chronic kidney disease and anemia.” N.Engl. J.Med 355(20): 2071-84.

13) Djoko Hargono, 1996. Sekelumit Mengenai Obat Nabati dan Sistem Imunitas.
Cermin Dunia Kedokteran. No. 108-5.

14) Edi Juniarianto, 1987. Penetapan Kandungan Zat Besi Pada Akar Dan Daun
Tapak Liman (Elephantopus scaber Linn.) FF UNAIR, Surabaya.

15) Ersley A.J, 2001. Anemia of Chronic Disease. In: Beutler E, Lichtman AM, Coller
SB, Kipps JT, Seligsohn U, editors. Williams Hematology. 6 th ed. vol 1. New
York: Mc Graw Hill. 2001. p. 481–7

16) Firkin F, Penington D, Chesterman C, Rush B. Anemia in Systemic Disorders,

Diagnosis in Normochromic Normocytic Anaemias. In: de Gruchy’s Clinical
Haematology in Medical Practice. 5 th ed. Blackwell Scientific Publication.
1989. p. 38–45

17) Georgantas, R.W, 3rd, R. Hildreth, et al. 2007. “CD34+ Hematopoietic Stem-
Progenitor cell micriRNA expression and function a sircuit diagram of
differentiation control.”Proc Natl Acad Sci U S A 104(8): 2750-5.

40
18) Gillespie T.W., 2003. Anemian in Cancer. Therapeutic Implication and intervations.
Cancer Nurs, 2003; 26 (2): 119 -128

19) Goldstein ML. Hematologic Disorders in The Elderly. In: Rossman I, editor. Clinical
Geriatrics. third ed. London: JB Lippincott Company. 1986. p . 388–91

20) Goodnough, Skikne B, Brugnara C. 2000. Erythropoetin, Iron and Erythropoiesis.

Blood August 1; 96 (3): 823–33

21) Gunawan, D. dan S. Mulyani. 2004. Ilmu Obat Alam (Farmakognosi) Jilid 1.
Penebar
22) Swadaya. Jakarta.

23) Haen PJ. Iron Deficiency Anemia. In: Principles of Hematology.Wm C Brown
Publishers. 1995. p. 117–25

24) Hamaguchi Y, Y. Kanakura, J.Fujita, 1987. Interleukin 4 As An Essential Factor For

In Vitro Clonagrowth Of Murine Conn ective Tissue -Type Mast Cell. Jurnal of
Medicine. Vol.165, 268-273.

25) Isbagio H, Setiati S. 2001. Proses Menua, Teori dan Implikasi Klinisnya. Dalam:
Suyono HS, Waspadji S, Lesmana L, Alwi I, Setiati S, Sundaru H et al, editor.
Buku Ajar Ilmu Penyakit Dalam. ed 3. Jilid II. Jakarta: Balai Penerbit FK–UI.. p.
257–63

26) Kenneth Murphy, Paul Travers, andMark Walport, 2008. Immunobiology. Seventh
Edition. Garlan Sciences Taylor and Francis Group, New York.

27) Kloppenburg, J dan Versteegh. 1988. Petunjuk Lengkap Mengenai Tanam-

Tanaman di Indinesia dan Khasiatnya sebagai Obat-obatan Tradisional, jilid II
Bagian Botani, CD.RS. Bethesda dan Andi Offset, Yogyakarta, (259 hal)

28) Koury MJ. The Anemia of Chronic Disease: TNF α involvement in erythroid
apoptosis. Blood 2002 July 15; 100 (2): 1–2

29) Kina, T., K. Ikuta, et al. (2000). "The monoclonal antibody TER-119 recognizes a
molecule associated with glycophorin A and specifically marks the late stages
of murine erythroid lineage." Br J Haematol 109(2): 280-87.

30) Kedde, M., M.J. Strsser, et al. (2007).”RNA-binding protein and l inhibits microRNA
access to target mRNA.” Cell 131(7): 1273-86.

31) Leonardo Sa, Papelbaum M. Anemia of Chronic Disease. Available from :

Hematology http : // www. medstudents.com. br / hemat / hemat 5. htm

32) Linch DC, Yates AP, Watts MJ. 1996. Classification of Anaemia. In: Haematology.
New York: Churchil-Livingstone.1996. p. 3

33) Lucie Widowati, 2007. Anemia Puslitbang Farmasi dan Obat Tradisional, Depkes
RI, Jakarta

34) Lisdawati V. Buah Mahkota dewa (Phaleria macrocarpa (Scheff Boerl) oksisitas,
Efek antitoksidan antikanker berdasarkan uji farmalogi: http://www
mahkotadewa. Com/ VPC/vivi.html. Tanggal akses 30 Januari 2010

41
35) Middelton E, Kandaswami C, Theoharides TC, 2000. The Effetc of Plant
Flavonoids on Mammalian Cells Implications for Inflamastion, Heart Disease
and Cancer. Pharmacological Review.52 (4):673-751

36) Murthy, R G., S.J. Greco, 2008. Tacl regulation by RNA-binding protein and
miRNA in bone marrow stroma: Implcation for hematopoietic activity.” Brain
Behav Immun 22(4): 442-50.

37) Nasroh, 2009. Tanaman Obat Indonesia. Herbal.com diakses tanggal 4 Agustus
2009.

38) Sastromidjoyo.s, 2001. Obat Asli Indonesia cetakan ke-6. Penerbit Dian Rakyat.
Jakarta.

39) Nowrousian.,M, Kasper.C., Oberhoff C.,Essers U., Voigmann R., Gallasch W.T
Pathophysiologyof Cancer- Related Anemia. In: Smyth.J.F.,Boogaert MA.,
R.M. Ehmer B.,Editors; RhErythropoietin in Cancer Supportive Treatment. 1st
ed. New York: Marcel Dekker: Inc; 1996. p.13 – 34.

40) Shinkai,Y.,G.Rathbun, K.. Lain,E.M, Oltz, V. Stewart, M.Mendelsoh, J.Charron, M.

Datta, F. Young, A.M. Stall, dan F.W. Alt. 1992. RAG-2 Dificient Mice Lack
Mature Lymphocytes Owing To Inability To Initiate V(D)J Rearanggrement .
The Cell. Vol.68:855-867.

41) Spangrude, 1991. Primary Imunodefeciency disease a Molecular and Genetic

approach by Hans D, Oches.C.I, Edvard Smith, Jenifer M, Jenifer Puck.
Identifity Cells, 2007. Medical- 726 hal.

42) Siswanto, Y.W. 2004. Penanganan Hasil Panen Tanaman Obat Komersial.
Penebar Swadaya. Jakarta.

43) Stephen J. Szilvassy, 2003. The Biology of Hematopoietic Stem Cell .Hematology
Angen Inc. Thousand Oaks, CA. USA.

44) Thomson JA, Itzkovitz-Eldor J, Shapiro SS, dkk. Embryonic stem cells lines
derived from human blastocyst. Science. 1998; 282: 1145-7.

45) Vannucchi, A.M., F. Paoletti, 2000. "Identification and characterization of a

bipotent (erythroid and megakaryocytic) cell precursor from the spleen of
phenylhydrazine-treated mice." Blood 95(8): 2559-68.

46) Walter T. Olivares M, Pizzaro F, Munoz C. Iron, anemia and infection .Nurt Review
1997:55(4):111-24)

47) Widodo,N, Khaur, K, Shrestha,.B., G., Takagi,Y., Ishii,T., Wadhwa,R., and Kaul,
S.C, 2007. Selective Killing of Cancer Cells by Leaf Extract of Ashwangandha:
Identification of a Tumor Inhybitory Factor and the first Moleculer Insights to Its
Effect Clin Cancer Res 2007;13(7)

42